Cargando…
Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM–comorbidity score
Comorbidities have been demonstrated to affect progression-free survival (PFS) and overall survival (OS), although their impact in multiple myeloma (MM) patients is as yet unsettled. We (1) assessed various comorbidities, (2) compared established comorbidity indices (CIs; Charlson comorbidity index...
Autores principales: | Kleber, M, Ihorst, G, Terhorst, M, Koch, B, Deschler, B, Wäsch, R, Engelhardt, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3255252/ https://www.ncbi.nlm.nih.gov/pubmed/22829196 http://dx.doi.org/10.1038/bcj.2011.34 |
Ejemplares similares
-
Validation of the Revised Myeloma Comorbidity Index and other comorbidity scores in a multicenter German study group multiple myeloma trial
por: Dold, Sandra Maria, et al.
Publicado: (2020) -
A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients
por: Engelhardt, Monika, et al.
Publicado: (2017) -
PB2143: PROGNOSTIC SIGNIFICANCE AND CLINICAL APPLICABILITY OF THE COMORBIDITY INDICES IN PATIENTS WITH MULTIPLE MYELOMA: IMWG AND SARC-F SCORE
por: Vukosavljevic, Nikola, et al.
Publicado: (2023) -
A Simplified Score to Quantify Comorbidity in COPD
por: Putcha, Nirupama, et al.
Publicado: (2014) -
An electronic application for rapidly calculating Charlson comorbidity score
por: Hall, William H, et al.
Publicado: (2004)